{"schema_version":"secwatch.filing_event.v1","accession":"0001837607-25-000032","form_type":"8-K","ticker":"AEON","cik":"0001837607","company_name":"AEON Biopharma, Inc.","filed_at":"2025-04-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.047304+00:00","generated_at":"2026-05-23T06:03:31.723425+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"NYSE American accepts AEON's compliance plan; delisting risk deferred to Aug 2026","bullets":["NYSE American accepted AEON's compliance plan on April 22, 2025, granting until August 3, 2026 to meet listing standards under Sections 1003(a)(i)-(iii).","AEON remains listed on NYSE American under symbol AEON during the Plan Period, subject to periodic progress reviews.","Failure to regain compliance or make sufficient progress by August 3, 2026 may lead to delisting proceedings.","Non-compliance was first disclosed in February 2025; plan submission deadline was March 5, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001837607-25-000032","json":"https://secwatch.observer/filing/0001837607-25-000032.json","markdown":"https://secwatch.observer/filing/0001837607-25-000032.md","text":"https://secwatch.observer/filing/0001837607-25-000032.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1837607/000183760725000032/0001837607-25-000032-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1837607/000183760725000032/aeon-20250422x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T06:03:31.723425+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}